You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 50 No. 7, July 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  CONSENSUS IN NEUROLOGY
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Stroke Therapy

It May Be Time for an Integrated Approach

John M. Hallenbeck, MD; Kai U. Frerichs, MD

Arch Neurol. 1993;50(7):768-770.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Stroke therapy research is generally based on the implicit assumption that one or, at most, a few factors or processes control the progressive damage that occurs in the early hours of brain ischemia. There is a finite probability that this assumption is inherently wrong. Among the many factors participating in progressive injury, none may be dominant or controlling, and the factors may act instead as a network of minor causes. If this possibility should turn out to be true, it would seriously degrade the likelihood of success of the "conventional" stroke therapy approaches.

The ischemic injury zone, which is the target for therapy, is viewed as having a densely ischemic core that would only respond to therapy instituted within minutes of the ictus. Surrounding the core is an "ischemic penumbra," a shell of tissue in a metastable state that is potentially viable if properly treated. The goal is to prevent . . . [Full Text PDF of this Article]


Author Affiliations

From the Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.


Footnotes

Accepted for publication November 2, 1992.

Reprint requests to Stroke Branch, Bldg 36, Room 4D04, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 (Dr Hallenbeck).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.